Oriola-KD Oyj A (OKDAV) - Cash Flow Conversion Efficiency

Latest as of March 2025: 0.229x

Based on the latest financial reports, Oriola-KD Oyj A (OKDAV) has a cash flow conversion efficiency ratio of 0.229x as of March 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€30.40 Million ≈ $35.54 Million USD) by net assets (€132.60 Million ≈ $155.02 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Oriola-KD Oyj A - Cash Flow Conversion Efficiency Trend (2006–2024)

This chart illustrates how Oriola-KD Oyj A's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Oriola-KD Oyj A (OKDAV) financial obligations for a breakdown of total debt and financial obligations.

Oriola-KD Oyj A Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Oriola-KD Oyj A ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Senheng New Retail Bhd
KLSE:5305
0.043x
Elin Electronics Limited
NSE:ELIN
0.065x
Tomei Consolidated Bhd
KLSE:7230
0.017x
Alpha Pro Tech Ltd
NYSE MKT:APT
0.000x
Llorente & Cuenca S.A.
MC:LLYC
0.283x
Mercor S.A.
WAR:MCR
-0.262x
Mobilicom Limited American Depositary Shares
NASDAQ:MOB
-0.330x
Poznanska Korporacja Budowlana Pekabex SA
WAR:PBX
-0.137x

Annual Cash Flow Conversion Efficiency for Oriola-KD Oyj A (2006–2024)

The table below shows the annual cash flow conversion efficiency of Oriola-KD Oyj A from 2006 to 2024. For the full company profile with market capitalisation and key ratios, see OKDAV market cap overview.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 €133.40 Million
≈ $155.96 Million
€38.70 Million
≈ $45.24 Million
0.290x +417.66%
2023-12-31 €171.30 Million
≈ $200.27 Million
€9.60 Million
≈ $11.22 Million
0.056x -83.77%
2022-12-31 €225.60 Million
≈ $263.75 Million
€77.90 Million
≈ $91.07 Million
0.345x +87.15%
2021-12-31 €216.80 Million
≈ $253.46 Million
€40.00 Million
≈ $46.76 Million
0.185x -46.33%
2020-12-31 €169.60 Million
≈ $198.28 Million
€58.30 Million
≈ $68.16 Million
0.344x -35.97%
2019-12-31 €157.20 Million
≈ $183.78 Million
€84.40 Million
≈ $98.67 Million
0.537x -5.21%
2018-12-31 €181.50 Million
≈ $212.19 Million
€102.80 Million
≈ $120.18 Million
0.566x +372.47%
2017-12-31 €197.70 Million
≈ $231.13 Million
€23.70 Million
≈ $27.71 Million
0.120x -38.66%
2016-12-31 €205.20 Million
≈ $239.90 Million
€40.10 Million
≈ $46.88 Million
0.195x -55.57%
2015-12-31 €194.60 Million
≈ $227.51 Million
€85.60 Million
≈ $100.08 Million
0.440x +562.69%
2014-12-31 €113.60 Million
≈ $132.81 Million
€-10.80 Million
≈ $-12.63 Million
-0.095x -188.72%
2013-12-31 €278.10 Million
≈ $325.13 Million
€29.80 Million
≈ $34.84 Million
0.107x -26.80%
2012-12-31 €314.90 Million
≈ $368.15 Million
€46.10 Million
≈ $53.90 Million
0.146x +55.93%
2011-12-31 €299.30 Million
≈ $349.91 Million
€28.10 Million
≈ $32.85 Million
0.094x -62.67%
2010-12-31 €352.70 Million
≈ $412.34 Million
€88.70 Million
≈ $103.70 Million
0.251x -33.95%
2009-12-31 €265.00 Million
≈ $309.81 Million
€100.90 Million
≈ $117.96 Million
0.381x +490.22%
2008-12-31 €185.50 Million
≈ $216.87 Million
€-18.10 Million
≈ $-21.16 Million
-0.098x -150.94%
2007-12-31 €203.60 Million
≈ $238.03 Million
€39.00 Million
≈ $45.60 Million
0.192x -20.30%
2006-12-31 €191.80 Million
≈ $224.23 Million
€46.10 Million
≈ $53.90 Million
0.240x --

About Oriola-KD Oyj A

HE:OKDAV Finland Pharmaceutical Retailers
Market Cap
$64.02 Million
€54.76 Million EUR
Market Cap Rank
#21054 Global
#104 in Finland
Share Price
€1.02
Change (1 day)
+0.00%
52-Week Range
€1.02 - €1.02
All Time High
€3.40
About

Oriola Oyj provides healthcare and wellbeing products primarily in Sweden and Finland. It also offers vitamins, food and food supplements, sports nutrients, wound care, beauty, and makeup related products. In addition, it provides pharmaceutical logistics and dose dispensing services. Further, the company engages in the wholesale of traded goods and over-the counter products, and special licensed… Read more